MXPA97003231A - Implantable and grafted protestism of allocation protosisimplantable cobalt-cromo-molibd - Google Patents
Implantable and grafted protestism of allocation protosisimplantable cobalt-cromo-molibdInfo
- Publication number
- MXPA97003231A MXPA97003231A MXPA/A/1997/003231A MX9703231A MXPA97003231A MX PA97003231 A MXPA97003231 A MX PA97003231A MX 9703231 A MX9703231 A MX 9703231A MX PA97003231 A MXPA97003231 A MX PA97003231A
- Authority
- MX
- Mexico
- Prior art keywords
- alloy
- medical device
- further characterized
- weight
- implantable
- Prior art date
Links
- 229910001182 Mo alloy Inorganic materials 0.000 claims abstract description 6
- 229910000531 Co alloy Inorganic materials 0.000 claims abstract description 4
- 229910000599 Cr alloy Inorganic materials 0.000 claims abstract 2
- 239000000956 alloy Substances 0.000 claims description 66
- 229910045601 alloy Inorganic materials 0.000 claims description 65
- REDXJYDRNCIFBQ-UHFFFAOYSA-N aluminium(3+) Chemical class [Al+3] REDXJYDRNCIFBQ-UHFFFAOYSA-N 0.000 claims description 51
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 37
- 239000000463 material Substances 0.000 claims description 18
- 229910052759 nickel Inorganic materials 0.000 claims description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 239000011651 chromium Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- VYZAMTAEIAYCRO-UHFFFAOYSA-N chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 229910052804 chromium Inorganic materials 0.000 claims description 4
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 4
- 229910052803 cobalt Inorganic materials 0.000 claims description 4
- 239000010941 cobalt Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 239000011148 porous material Substances 0.000 claims 1
- 239000004753 textile Substances 0.000 description 25
- 238000005482 strain hardening Methods 0.000 description 17
- 238000009954 braiding Methods 0.000 description 14
- 229910052751 metal Inorganic materials 0.000 description 11
- 239000002184 metal Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 239000000969 carrier Substances 0.000 description 7
- 239000007943 implant Substances 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 229910001220 stainless steel Inorganic materials 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- 230000032683 aging Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- -1 nickel-titanium Chemical compound 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 238000005452 bending Methods 0.000 description 3
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920004934 Dacron® Polymers 0.000 description 2
- 239000004698 Polyethylene (PE) Substances 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000002349 favourable Effects 0.000 description 2
- 230000002431 foraging Effects 0.000 description 2
- 238000005242 forging Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 210000001519 tissues Anatomy 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- 229910000619 316 stainless steel Inorganic materials 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 210000001124 Body Fluids Anatomy 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005275 alloying Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- UIMGJWSPQNXYNK-UHFFFAOYSA-N azane;titanium Chemical class N.[Ti] UIMGJWSPQNXYNK-UHFFFAOYSA-N 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- QZIQJVCYUQZDIR-UHFFFAOYSA-N mechlorethamine hydrochloride Chemical compound Cl.ClCCN(C)CCCl QZIQJVCYUQZDIR-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000268 renotropic Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 200000000009 stenosis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 230000002485 urinary Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005491 wire drawing Methods 0.000 description 1
Abstract
The present invention relates to an implantable medical device comprised of a tubular and radially expandable structure that includes at least one elongate element formed of cobalt, chromium and molybdenum alloy (Co-Cr-Mo) containing less than about 5 percent in weight of níqu
Description
IMPLANTABLE AND IMPARTABLE PROSTHESIS OF IMPLANTOBLE PROSTHESIS OF ALLOY COBOLTO-CROMO-MO IBDENO
FIELD OF THE INVENTION
The present invention relates generally to radially expandable medical and plantable prostheses that include implantable prosthetic graft. In particular, the present invention is an implantable prosthesis and graft of implantable prosthesis of cobalt-chromium-rnolibdene alloy.
BACKGROUND OF THE INVENTION
Medical prostheses are well known and commercially available. One type of implantable prosthesis, known as a self-expanding implantable prosthesis, is generally described in U.S. Patent No. 4,655,771, for Uallsten, U.S. Patent 5,061,275, for U listen et al., International Application Publication No. UO 94/24961, and International Application Publication No. Uo 94/16646. These devices are used within body vessels of humans and other animals for a variety of medical applications including stenosis treatment, maintenance of openings in the urinary, biliary, esophageal and renal tracts, and vena cava filters to combat embolism.
Briefly, self-expandable implantable prostheses of the type described in the patent documents identified above are formed from a number of filaments or elastic elements that are helically wound and woven into a braid-like configuration. The implantable prostheses assume a substantially tubular shape in their unloaded state, or expanded when they are not subjected to external forces. When subjected to internally directed radial forces, the plantable prostheses are forced into a reduced radius and loaded or compressed in extended length. A releasing device that retains the implantable prosthesis in its compressed state is used to release the implantable prosthesis to a treatment site through the vessels in the body. The flexible nature and reduced radius of the compressed implantable prosthesis allow it to be delivered through relatively small and curved vessels. After an implantable prosthesis is positioned at the treatment site, the delivery device acts to release the implant prosthesis, thereby allowing the prosthesis to self-expand within the body vessel. Then, the delivery device is separated from the implant prosthesis and removed from the patient. The implantable prosthesis remains in the vessel at the treatment site. Commonly used materials for self-expandable implantable prosthetic filaments include Elgiloy® and PhynoxR flexible alloys. The Elg? LoyR alloy is available from Carpenter Technology Corporation of Reading Pennsylvania. The PhynoxR alloy is available from Metal Irnphy of I phy, France. Both of these metals are cobalt-based alloys that also include chromium, iron, nickel and rnolibdene. Other materials used for self-expandable implantable prosthetic filaments are 316 stainless steel and MP35N alloy, which is available from Carpenter Technology Corporation and Latrobe Steel. Campany from Latrobe, Pennsylvania, and nickel-titanium superelastic alloy Nitinol, which is available from Shape Mernory Applications of Santa Clara, California. The resistance to deformation and the modulus of elasticity of the filaments that form the self-expanding implantable prosthesis are important characteristics. The flexibility characteristics of an alloy and the implantable prostheses formed therefrom are determined to a large extent by the modulus of elasticity of the alloy. In general, the modulus of elasticity must be high enough to allow the prosthesis to spring back towards its discharge state of the compressed state, with sufficient radial force to meet the requirements of the application for which the prosthesis was designed. The material must also have sufficient strength so that it can be compressed for release without being plastically deformed or permanently bent. ElgiloyR, PhynoxR, MP35N and stainless steel are all high strength and high modulus metals. Nititol has a relatively low strength and modulus. The alloys of Elgiloy "*, PhynoxR, MP35N and stainless steel all contain approximately 10% to 20% nickel." Nickel increases the ductility of the alloys, improving their ability to be stretched or mechanically molded (ie, reduced in size). cross-sectional area) in wire of relatively thin diameters required for implantable prostheses (between approximately 0.025 mm and 0.500 mm) by a procedure known as cold-working, cold-working is also convenient because it increases the strength of the material. However, the deformation resistance that can be obtained by cold working of Elg? loyR, PhynoxR, MP35N, Nit ol and stainless steel alloys (e.g., approximately 1738 Mpa for Elg? loyR alloy) is generally not sufficiently high for many applications of implantable prostheses.As a result, impiantable prostheses manufactured from cold-worked Elg? loyR and PhynoxR (also known as set) are typically treated with heat after being cold-worked, a process that significantly increases their resistance to deformation and thereby allows the fabrication of implantable prostheses with filaments of relatively smaller diameter. By way of example, the deformation resistance of the Elg? LoyR alloy can be increased by heat treatment to about 2861 MPa. The strength of stainless steel and Nitol alloys can not be significantly increased by means of heat treatment, so that these materials are not typically used in the construction of expandable and expandable prostheses with high radial strength. Cold working is a method by which the metal is plastically deformed to a particular shape and hardened (deformation) to increase the strength of the material. The processes that can be carried out to carry out cold working are stretching, rolling, extrusion, forging, setting and the like. Is the starting material introduced into the cold-working process in the form of ingots, rods, bars, small ingots, discs? other appropriate forms. The workpieces are forced to pass through a given die, fill a die cavity, or conform to the given shape. The output of the cold-working process is typically material with a new shape and with superior strength and hardness of the hardening of metallurgical deformation that occurs with the plastic deformation. In the cold-working process, described in International Publication No. UO 94/16646, ingots, rods, rods or wire are stretched or extruded through a series of round dice and an incremental reduction in material diameter is achieved. that the final desired wire size is obtained to braid the implantable prosthesis. The filaments of the implantable prostheses described above can form a lattice structure that includes large amounts of open area. However, in some cases this large open area allows the tissue to grow through the implantible prosthesis and obstructs portions of the tract that were opened by the implantable prosthesis. The use of covered implantable prostheses is generally known for applications where tissue growth of this type is inconvenient, as well as for applications in which portions of the tract undergoing treatment (aneurysms) are weak or have spaces. Implantable prostheses and implantable prosthetic grafts can be covered, for example, by means of porous membranes, interwoven organic filaments or the like. Implantable prostheses of this type are sometimes known as prostheses or grafts of coated prostheses and are described, for example in Experimental Assessment of Newly Devised Trans-Catheter Stent-Graft for Atopic Dissection, Annual of Thoracic Surgery, M. Kato et al., 59: 908-915 (1995). The membranes incorporated in prosthetic grafts are typically formed from polymeric materials. However, many of these polymeric materials can degrade when exposed to temperatures used for hot-treated alloys of the type described above. Therefore, the need to heat treat the lattice structure of the metal alloy and the temperature sensitivities of the polymers used to form the membranes thereof, restrict the designs of the prosthetic grafts and their application.
In addition to stretching elongated filaments for implants implants of interwoven elements of the type described above and in the UA North American Patent No. 4,655,771, metal alloy materials are stretched or extruded into other forms for manufacturing implantable prostheses. U.S. Patent No. 4,733,655 to Palrnaz, refers to a plantable prosthesis i made from a stretched or extruded stainless steel tube. US Pat. No. 4,800,882 to Giant? Rco, refers to a plantable prosthesis i assembled from drawn stainless steel wire. Other known implantable prostheses are made of stretched, extruded or rolled nickel-titanium alloy tape. Alloys of cobalt, chromium, molybdenum (Co-Cr-Mo) have been used in medical implant applications. In ASTM Standard Designations F 75 and F 799, chemical, mechanical and metallurgical requirements are published for alloys of these types used for surgical implant applications. One such alloy known as BioDur Carpenter CCMR is commercially available from Carpenter Tecnhology Corporation. These chromium-cobalt-molybdenum alloys are highly biocornpatible. However, since they have a relatively low nickel content (approximately 1% at most), the cobalt-o-rnolibdene alloys have relatively low ductilities and high work hardening rates that limit their moldability. For this reason, conventional wisdom has been that these alloys can not be cold drawn to reach the fine wire diameters required for implantable prostheses and implantable prosthetic grafts. There is a continuing need for implantable prostheses and improved implantable prosthetic grafts. In particular, there is a need for implantable prostheses and implants of implantable prostheses made from highly biocompatible alloys that have high resistance to deformation and high modulus of elasticity. There is also a need for implantable prostheses and implantable prosthetic grafts that do not require heat treatment.
BRIEF DESCRIPTION OF THE INVENTION
The present invention relates to an improved implantable medical device comprised of a tubular and radially expandable structure that includes at least one elongate element formed from cobalt o-chrome-rnolibdene alloy (Co-Cr-Mo) containing less than about 5% nickel. The CO-CR-Mo alloy is highly biocompatible and has a relatively high resistance to deformation and modulus of elasticity. One embodiment of the invention is a radially expandable self-expanding stent that includes a plurality of elongated Co-CR-Mo alloy filaments that are interwoven in a braid configuration. The alloy contains at least 50% by weight of cobalt, between about 26 and 31% by weight of chromium, between about 4 to 8% by weight of molybdenum and less than about.% By weight of nickel.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is an isometric view of an embodiment of the present invention, illustrating an implantable prosthesis having a braided configuration of filaments. Figure 2 is a partially longitudinal cross-sectional view of the implantable prosthesis shown in Figure 1. Figure 3 is a cross-sectional view of one of the filaments of the implantable prosthesis shown in Figure 1. Figure 4 is a cross sectional view of a mixed filament according to another embodiment of the invention. Figure 5 is a photograph of an implantable prosthesis graft in accordance with the present invention. Figure 6 is a schematic illustration of different discrete layers that can be formed by the three-dimensional braiding of multiple chains and incorporated in the implantable prosthesis graft shown in Figure 5. Figures 7-9 schematically illustrate a procedure for manufacturing the graft. of unplantable prosthesis shown in Figure 5. Figure 10 schematically illustrates an alternative procedure for manufacturing the implantable prosthesis graft shown in Figure 5.
DETAIL DESCRIPTION »OF THE PREFERRED MODALITIES
In FIGS. 1 and 2, an implantable prosthesis 10 according to the present invention is generally illustrated. The implantable prosthesis 10 is a tubular device formed of two groups of elongated elements or filaments 12, oppositely directed, parallel, spaced apart and helically wound. The groups of filaments 12 are interwoven in a braided configuration up and down, and are interconnected at points such as 14 to form an open, open structure. The invention is based on the discovery that, contrary to conventional wisdom, certain cobalt-chromium-rnolibdene (Co-Cr-Mo) alloys containing less than about 5% by weight of nickel can be stretched or molded in some other way by cold-working in forged elements such as filaments 12 suitable for implantable prostheses 10. Non-limiting examples of cold-working methods that can be used to form said Co-Cr-Mo alloying elements include wire drawing, tube stretching and Similar. At least one, and in a preferred embodiment all, the filaments 12 are formed from commercially available Co-Cr-Mo alloy, which contains less than 2% by weight of nickel. The methods for manufacturing plantable prostheses 10 are generally known and described, for example, in US Pat. No. 4,655,771, Uallsten, North American Patent Nurn. 5,061,275, from Ualleten et al., And International Application Publications Nos. UO 94/24961 and UO 94/16646. In figures 1 and 2 the implantable prosthesis 10 is shown in its expanded or relaxed state, that is, in the configuration it assumes when it is not subjected to external loads or stresses. The filaments 12 are elastic, allowing radial understanding, of the implantable prosthesis 10 up to a configuration or reduced radius state of extended length suitable for delivery to the desired location or treatment site through a body vessel (i.e. transluminally). The implantable prosthesis 10 is also self-expandable from the compressed state and is axially flexible. Stated another way, the implantable prosthesis 10 is a radially and axially flexible tubular body having a predetermined diameter that is variable under axial movement of the ends of the body in relation to each other. The implantable prosthesis 10 is composed of a plurality of individually rigid but flexible elastic twisted filaments or elements 12, each of which extends in a helical configuration along a longitudinal centerline of the body as a common axis. At least one, and in a preferred modality, all the filaments 12 are formed of Co-Cr-Mo alloy containing less than about 5% by weight of nickel. The filaments 12 define a body that radially self-expands. The body is provided by a first number of filaments 12 having a common winding direction but displaced axially in relation to each other, and crossing a second number of filaments 12 also displaced axially in relation to each other but having an opposite direction of winding. The tubular and self-expanding body or structure formed by the interwoven filaments 12 is a prosthetically functional primary structure of implantable prosthesis 10, and for this reason, the device can be considered to consist substantially of this structure for the exclusion of other structures. However, it is known that other structures and characteristics can be included in the implantable prostheses, and in particular, characteristics that increase or cooperate with the tubular and self-expanding structure or that facilitate the implantation of the structure. One example is the inclusion of radiopaque markers on the structure that are used to visualize the position of the implantable prosthesis by fluoroscopy during implantation. Other examples include crushable threads? other structures to facilitate replacement and removal of the implantable prosthesis. Implantable prostheses of these types nevertheless still consist substantially of the tubular and self-expanding structure formed by interwoven filaments 12 and shown in Figures 1 and 2., many of the desirable properties and characteristics of the implantable prosthesis 10 will be present if some, but not all, of the filaments 12 consist of the Co-Cr ~ Mo alloy. Figure 3 is a cross-sectional view of one embodiment of the filaments 12 of the Co-Cr-Mo alloy. As shown, the filaments 12 are substantially homogeneous in cross section. Commercially available alloys may have minor fluctuations in concentration of components while remaining substantially homogeneous. The composition of the filaments 12 can also be homogeneous in the longitudinal direction. Figure 4 is a cross-sectional illustration of a mixed filament 22 including a central core 24 and a cover 26 surrounding the core. The filaments 22 can be used to fabricate implantable prostheses such as 12, and are described in greater detail in International Application UO 94/16646. The core 24 or the cover 26 can be formed from the Co-Ci- shaped alloy or described herein. A preferred embodiment of an implantable prosthesis such as 12 is formed from mixed filaments 24 having frames 26 of the Co-Cr-Mo set alloy. The filaments 12 can be formed from a wide variety of Co-Cr-Mo alloys containing less than about 5% by weight of nickel, preferably containing less than about 2% nickel, and preferably containing no more than about 1% of nickel. The alloys may include nitrogen (N) in an amount of between 0.00% by weight and approximately 0.25% by weight, and carbon (O in an amount of between about 0.00% by weight and about 0.35% by weight). the alloy can vary up to a maximum of about 31.0% by weight, and is preferably contained in an amount of between about 26.0% by weight and 30.0% by weight.The amount of Mo in the alloy can vary up to a maximum of about 8.0 % by weight, and is preferably contained in a blend of between about 5.0 wt% and about 7.0 wt% Other elements that may be contained in the Co-Cr-Mo alloy, preferably are in amounts not greater than about 1.0. % by weight, and are iron (Fe), silicon (Si), manganese (Mn), copper (Cu), phosphorus (P), sulfur (S), and tungsten (U) .The rest of the composition of the alloy can be Co, which is preferably contained in a antity of at least 60.0% by weight. Any known or otherwise conventional cold-working method can be used to form the elements 12 and 22. Non-limiting examples include drawing, rolling, extruding, forging, setting, and the like. The Co-Cr-Mo alloy can be introduced into the cold-working process in the form of ingots, rods, bars, small ingots, discs? other appropriate configurations. The sample filaments 12 were cold drawn from BioDur Carpenter CCMR alloy, which is available commercially from Carpenter Technology Corporation of Reading, Pennsylvania. The published composition for this alloy is Co, 26 Cr, 6 Mo, 1 Si, 1 Fe, 1 Mn, 1 Ni, 0.5 U, 0.5 C ?, 0.18 N, 0.05 C, 0.015 P, 0.015 S. The filaments 12 to The wire alloys of this alloy have a nominal diameter of approximately 0.1 millimeter which was cold stretched to an end of approximately 50% - 80% reduction in its area by Fort Uayne Metals Research Products Corporation of Fort Uayne, Indiana. The ultimate tensile strength of this was measured as drawn wire and was found to be approximately 2889 MPa. The measured deformation resistance of the stretched wire samples was 2489 MPa. The measured elongation of stretched wire samples was 2.4%. The measured modulus of elasticity of the samples was 168.238 MPa. The mean modulus of flexure determined in the stretched sample was 157.896 MPa. The average cutting modulus determined in the stretched samples was 85, 884 MPa. A number of CCMR alloy samples were also heat treated in argon. A heat-treated wire sample was tested for approximately 13 minutes at 500 ° C and found to have a final tensile strength of about 3185 MPa, a resistance to deformation of about 3068 MPa, an elongation of about 2%, and a modulus of elasticity of approximately 193,750 MPa. A heat-treated sample was tested for approximately 13 minutes at 600 ° C and found to have a final tensile strength of about 3172 MPa, a deformation strength of about 2992 MPa, an elongation of about 2%, a modulus of elasticity of approximately 204,092 MPa, an average flexural modulus of approximately 170,609 MPa and an average shear modulus of approximately 96,627 MPa. Another sample of heat treated wire was tested for approximately 13 minutes at 700 ° C and found to have a final tensile strength of about 2965 MPa, a resistance to deformation of about 2710 MPa, an elongation of about 2% and a modulus of elasticity of approximately 207.540 MPa. The deformation resistance and modulus of elasticity of the sample as drawn wire of CCM alloy are generally similar to those of heat treated wire of Elgiloy alloy of a similar diameter. The implantable prostheses made with CCMR alloy wire can therefore have spring, radial pressure and wire strength and tension (ie, properties) properties similar to those of similarly sized plantable prostheses i manufactured from ElgiloyR alloy wire . With this, equivalent physical characteristics of plantable prosthesis can be obtained from an implantable prosthesis having a relatively low nickel content. In addition, relatively high levels of strength are achieved only by cold-working the alloy. Implantable prostheses made of CCMR alloy wire do not therefore need to be heat treated to achieve the required strength levels for certain applications. Another desirable feature of the CCMR alloy wire is that it has a high surface hardness and a smooth surface finish. In the stretched state, the measured hardness values of the CCMR alloy wire samples were between about 46.2 and about 48.7 in the Rockwell C scale and averaged about 47.3 on the Rockwell C scale. The heat treated samples of the CCMR alloy wire had measured hardness values between about 55.2 and 57.8 on the Rockwell C scale, and averaged approximately 56.6 on the Rockwell C scale. These hardness values are relatively high compared to stainless steel (approximately 34 to 40 on the Rockwell C scale when stretched) and ElgiloyR alloy (approximately 42.2-44 on the Rockwell C scale when stretched, and approximately 53.7-55.4 on the Rockwell C scale, when it is aged). These relatively high surface hardness characteristics are advantageous in self-expanding implantable prostheses since they improve the resistance to use of the filaments 12 and reduce friction at the points 14 in which the filament intersects with others in the implant-able prosthesis 10. 5 is an illustration of a prosthesis graft 30 including filaments or structural chains 32 of Co-Cr-Mo alloy, of the type incorporated in the implantable prosthesis 10 and described above (for example filaments 12). As shown, the structural chains 32 of Co-Cr-Mo alloy are braided with layers of more closely woven textile chains 42 that reduce permeability. The structural chains 32 are selectively configured prior to their braiding with the textile chains 42, either by a permanent thermal deformation or by selective plastic deformation, and in any case they are configured without adversely affecting the textile chains. The plastic deformation of structural chains 32 by cold working is advantageous, since it allows a continuous cold-working process followed by braiding. The result is a braided prosthesis that incorporates the strength, elasticity and scale of radii associated with self-expandable implantable prostheses without the need for heat treatment for aging hardening and the impermeability associated with vascular grafts. Figure 6 schematically illustrates the manner in which multiple structural chains 32 and multiple textile chains 42 are braided together to form several discrete layers of prosthesis 30. These include an inner (radially inward) layer 44 consisting primarily of textile chains. 42, an outer layer 46 which also consists mainly of the textile chains, and a middle layer 48 that incorporates the structural chains 32. The layers 44-48 are formed simultaneously in a single braiding operation that also interlaces the layers, in the that at least one of the chains of each of the layers is braided in one of the other layers. In a preferred approach, the inner layer 44 and the outer layer 46 are formed substantially completely from textile chains 42, while the middle layer 48 is a braided combination of textile chains 42 and structural chains 32, for example in a one-to-one relationship. one, or two to one relationship in favor of textile chains. The inner layer 44 includes a first group of its textile chains that extend into the middle layer, and a second group of its textile chains that extend through the middle layer into the outer layer, and then back into the inner layer. . These groups together can comprise a relatively small percentage of the textile chains of the layer 44. The middle layer 48 and the outer layer 46 similarly have groups of textile chains extending to the other layers. In this way, there is a substantial intermixing between chains of the different layers for effective interleaving, although the layers remain different from each other in character. The textile chains 42 are preferably multi-filament yarns, although they may be monofilaments. In any case, the textile chains are much thinner than the structural chains 32, ranging from about 10 to 400 denier. The individual filaments of the multifilament yarns can vary from about 0.25 to about 10 denier. Multi-filament yarns generally have a high degree of deformation, which may or may not include elasticity. Suitable materials include PET, polypropylene, polyurethane, urethane polycarbonate, HDPE, polyethylene, silicone, PTFE, ePTFE and polyolefin. A suitable high molecular weight polyethylene is sold under the brand name "Spectra". The fine textile chains are closely woven into layers 44, 46 and 48, and can be considered to form a textile liner or fabric in each layer. Due to the fineness of the textile chains 42 and a narrow or tight fabric, the textile linings can be multi-porous, still substantially impervious to body fluids. Also, the textile lining layers are highly deformable, adjusting to changes in the lattice shape formed by the structural chains 32 to the extent that the prosthesis 30 radially self-expands or radially compresses. The shape of the reticle determines in this way the shape of the prosthesis 30. A particularly favorable structure for the prosthesis 30 has a middle layer 48 formed by braided metal structural chains 32 with multi-strand strands of dacron (polyester) as the textile chains. 42. Metal structural chains exhibit high strength in terms of elastic modulus. By contrast, for example, polyethylene has an elastic modulus in the range of approximately 1.4-3.85 x 10a kg / cmz, and other polymeric materials have elastic moduli in this order of magnitude. Therefore, for a given diameter of chain, helical diameter and helical tilt, a lattice of metal chains is considerably more resistant to radial compression, and provides a greater residual force for sharp attachment. Dacron polyester filament yarn has a high elastic recovery and elongation (up to 36% for polyester fiber) and a low elastic pattern, which ensures that the textile liner 40 fits the reticle. To achieve favorable characteristics of implantable prostheses and implantable prosthetic grafts, the prostheses 30 can be manufactured in accordance with several steps as illustrated in Figures 7-9. Figure 7 shows two structural chains (metal monofilaments) 32a and 32b, one of each group of oppositely directed structural chains, wound around a mandrel 60 and supported by respective coils 62 and 64. Although only the chains 32a and 32b are illustrated for convenience, it is appreciated that all structural chains are wound around the mandrel and held together for formation. However, only structural chains are present, as formation occurs before braiding with textile chains. Hardening by aging is carried out inside a furnace 66 in a vacuum or protective atmosphere. The temperatures are within the range of approximately 350-1000 ° C, with the specific temperature depending on the structural material. The filaments extend one over the other to form multiple intersections, one of which is indicated at 68. The coils, including 62 and 64, are placed to apply tension to their respective chains during aging hardening. The proper duration of aging hardening varies with materials and dimensions, but can be as short as 30 seconds, up to about 5 hours. After hardening by aging, the structural chains are allowed to cool, whereby each structural chain retains the helical shape as its nominal form. In the context of elastic materials, "nominal form" refers to the form in a relaxed state, that is when there is no external effort. Metal monofilaments hardened by aging are highly elastic, that is, deformable under external stress, but return elastically to the nominal form when they are free from external stress. Braiding occurs of the structural chains 32 and the textile chains 42 after selective formation. Figure 8 illustrates schematically a braiding apparatus 70 including a cylindrical carrier assembly 72 including several annular arrangements of coils, two of the coils are indicated at 80a and SOb. The apparatus further includes a mandrel 78, centered within the cylindrical assembly and movable longitudinally relative to the assembly, as indicated by the arrow. Figure 9 illustrates part of the carrier assembly 72 in greater detail, to reveal five annular arrangements or groups of carrier coils indicated at 80, 82, 84, 86 and 88. These groups are separated coaxially and axially, each includes forty-eight coils , twenty-four coils for respective dextrorotatory and levorotatory windings around the mandrel 78. Although those skilled in the art are familiar with the use of braiding machinery, it is emphasized herein that the braiding apparatus 70 is configured as or described in the patent publication. International previously mentioned No. UO91 / 10766. Suitable braiding machinery is available from Albany International Research Company of Mansfield Massachusette. Figure 10 illustrates schematically an alternative three dimensional braiding apparatus 92 in which the structural chains are selectively formed by cold treatment. In particular, a cylindrical carrier assembly 94 is mounted concentrically on a longitudinally movable mandrel 96. As before, the carrier assembly supports multiple coils in arrangements that include several groups of concentric circular coils, two of the coils are indicated at 98 and 100. A structural chain 32 has been wound on the bobbin 98, while the bobbin 100 carries a textile chain 42. The structural chain is not thermally formed before braiding, and thus, at the beginning, it has a linear nominal shape. The structural chain 32 is plastically deformed by cold treatment when it is moved from the coil 98 to the mandrel. Along the path traveled by the chain 32, there is arranged a small diagonal forming pulley 102 and a larger diameter idle pulley 104. Although the pulleys 102 and 104 are shown in lateral elevation in FIGS. 10, it should be understood that in the actual braiding device, the pulley 102 is orthogonal to the pulley 104 to effect the selected formation of the chain 32. The forming pulley 102 it exerts a bending stress on the movable structural chain transported around this pulley, particularly on radially outer portions of the chain. The coil 98 is supported on a carrier including a clutch (not shown) adjustable to adjust the tension applied to the chain, thereby adjusting the amount of bending stress. The tension is controlled so that the bending stress, at least along the radially outer portions of the chain along the pulley 102, exceeds the deformation resistance of the material. The appropriate level of tension is on the scale of approximately 200-1000 gms, depending on factors such as the material, the diameter of the monofilament and the radius of flexure around the pulley 102. The result is a plastic deformation of cold working. The plastic movement is continuous, and changes the nominal shape of the structural chain, from linear to helecoidal. Furthermore, in this regard, it is observed that the pulley 102 imparts a nominal curved shape to the structural chain in any case, and that the nominal helecoidal shape with the desired inclination is obtained by suitable orientation of the pulley with respect to the carrier assembly, maintaining at the same time the desired tension in the chain. No heat treatment is necessary for aging hardening after braiding when using structural metal filaments with sufficiently high deformation resistance and modulus, such as the filament of the Co-Cr-Mo alloy described herein. Although the present invention has been described in reference to preferred embodiments, those skilled in the art will recognize that changes in form and detail can be made without departing from the spirit and scope of the invention. In particular, expandable balloon implantable prostheses and other implantable prostheses made in accordance with the present invention will also offer important advantages with the elements formed of Co-Cr-Mo alloy containing compounds of about five percent by weight of nickel.
Claims (15)
1. An implantable medical device comprised of a tubular and radially expandable structure including at least one elongate element formed of cobalt, chromium and molybdenum alloy (Co-Cr-Mo) containing less than about 5 weight percent nickel.
The medical device according to claim 1, further characterized in that the device is comprised of a lattice structure that includes at least one elongate element formed of Co-Cr-Mo alloy.
3. The medical device according to claims 1 and 2, further characterized in that the device is comprised of a radially self-expanding structure that includes at least one elongate element formed of Co-Cr-Mo alloy.
The medical device according to claims 1-3, further characterized in that the device comprises an axially flexible structure including a plurality of the elongate elements formed of Co-Cr-Mo alloy which are woven in a configuration similar to braid.
5. The medical device according to claims 1-4, further characterized in that the Co-Cr-Mo alloy contains less than about 2 weight percent in nickel.
6. The medical device according to claims 1-4, further characterized in that the Co-Cr-Mo alloy contains a maximum of about 1 percent by weight of nickel.
7. The medical device according to claims 1-6, further characterized in that the Co-Cr-Mo alloy contains between about 0 and about 0.25 percent by weight of nitrogen (N), and between about 0 and about 0.35 percent by weight. weight of carbon (C).
8. The medical device according to claims 1-6, further characterized in that the Co-Cr-Mo alloy contains between about 0.15 and about 0.20 weight percent nitrogen (N) and between about 0.01 and about 0.10 weight percent. of carbon.
9. The medical device according to claims 1-8, further characterized in that the structure consists substantially of at least one filament of Co-Cr-Mo alloy.
10. The medical device according to claims 1-9, further characterized in that each elongated element of Co-C.r-Mo is formed of a filament of diameter at least 50% reduced.
11. The medical device according to claims 1-10, further characterized in that each Co-Cr-Mo element has a stretching hardness of at least 45.5 on the Rockwell C scale.
12. The medical device according to claims 1-11, further characterized in that each Co-Cr-Mo filament is free from heat treatment after stretching.
The medical device according to claims 1-6 and 9-12, further characterized in that the Co-Cr-Mo alloy contains at least about 50 percent by weight of cobalt, between about 25 to 31 percent by weight of chrome, between about 4 to 8 weight percent of rnolibdene, between about 0.15 to 0.20 weight percent nitrogen and between about 0.01 to 0.10 weight percent carbon.
14. The medical device of claims 1-13, further characterized in that the device includes a membrane of coextensive porous material with at least a portion of the length of the expandable structure.
15. The medical device according to claim 14, further characterized in that the membrane is formed of polymeric material. RFfUMEN OF THE INVENTION A self-expanding implantable prosthesis (10) formed of helically wound and braided filaments (14) of cobalt, chromium and molybdenum-set alloy containing less than about five percent by weight of nickel; The composition of the alloy from which a modality of the implantable prosthesis is formed is Co-26Cr-6Mo-lSi-lFe-lMn-lNi. EA / avc- * mmrn * fac- * apm P97 / 324
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/640,253 US5891191A (en) | 1996-04-30 | 1996-04-30 | Cobalt-chromium-molybdenum alloy stent and stent-graft |
US08640253 | 1996-04-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA97003231A true MXPA97003231A (en) | 1998-04-01 |
MX9703231A MX9703231A (en) | 1998-04-30 |
Family
ID=24567467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9703231A MX9703231A (en) | 1996-04-30 | 1997-04-29 | Cobalt-chromium-molybdenum alloy stent and stent-graft. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5891191A (en) |
EP (1) | EP0804934B1 (en) |
JP (1) | JPH1043314A (en) |
AT (1) | ATE246526T1 (en) |
AU (1) | AU726102B2 (en) |
CA (1) | CA2201542C (en) |
DE (1) | DE69723905T2 (en) |
DK (1) | DK0804934T3 (en) |
ES (1) | ES2202546T3 (en) |
MX (1) | MX9703231A (en) |
PT (1) | PT804934E (en) |
Families Citing this family (320)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6682608B2 (en) * | 1990-12-18 | 2004-01-27 | Advanced Cardiovascular Systems, Inc. | Superelastic guiding member |
US7101392B2 (en) * | 1992-03-31 | 2006-09-05 | Boston Scientific Corporation | Tubular medical endoprostheses |
JPH07505316A (en) * | 1992-03-31 | 1995-06-15 | ボストン サイエンティフィック コーポレーション | medical wire |
US20050059889A1 (en) * | 1996-10-16 | 2005-03-17 | Schneider (Usa) Inc., A Minnesota Corporation | Clad composite stent |
US5636641A (en) * | 1994-07-25 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | High strength member for intracorporeal use |
US6736843B1 (en) * | 1994-07-25 | 2004-05-18 | Advanced Cardiovascular Systems, Inc. | Cylindrically-shaped balloon-expandable stent |
US6348066B1 (en) * | 1995-11-07 | 2002-02-19 | Corvita Corporation | Modular endoluminal stent-grafts and methods for their use |
US6592617B2 (en) * | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
IT1291001B1 (en) * | 1997-01-09 | 1998-12-14 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT AND ITS PRODUCTION PROCESS |
US5957974A (en) | 1997-01-23 | 1999-09-28 | Schneider (Usa) Inc | Stent graft with braided polymeric sleeve |
US8353948B2 (en) | 1997-01-24 | 2013-01-15 | Celonova Stent, Inc. | Fracture-resistant helical stent incorporating bistable cells and methods of use |
DE69732229T2 (en) * | 1997-07-17 | 2005-12-29 | Schneider (Europe) Gmbh | Stent and manufacturing process for it |
US5984957A (en) * | 1997-08-12 | 1999-11-16 | Schneider (Usa) Inc | Radially expanded prostheses with axial diameter control |
US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US6520983B1 (en) | 1998-03-31 | 2003-02-18 | Scimed Life Systems, Inc. | Stent delivery system |
US6264689B1 (en) | 1998-03-31 | 2001-07-24 | Scimed Life Systems, Incorporated | Low profile medical stent |
US6387060B1 (en) * | 1998-06-17 | 2002-05-14 | Advanced Cardiovascular Systems, Inc. | Composite radiopaque intracorporeal product |
DE59913189D1 (en) | 1998-06-25 | 2006-05-04 | Biotronik Ag | Implantable, bioabsorbable vessel wall support, in particular coronary stent |
US20040267349A1 (en) | 2003-06-27 | 2004-12-30 | Kobi Richter | Amorphous metal alloy medical devices |
US20070219642A1 (en) * | 1998-12-03 | 2007-09-20 | Jacob Richter | Hybrid stent having a fiber or wire backbone |
US20060122691A1 (en) * | 1998-12-03 | 2006-06-08 | Jacob Richter | Hybrid stent |
US20060178727A1 (en) * | 1998-12-03 | 2006-08-10 | Jacob Richter | Hybrid amorphous metal alloy stent |
US8382821B2 (en) * | 1998-12-03 | 2013-02-26 | Medinol Ltd. | Helical hybrid stent |
US6234981B1 (en) | 1998-12-30 | 2001-05-22 | Advanced Cardiovascular Systems, Inc. | Vapor deposition coated intracorporeal device |
US7717864B1 (en) | 1998-12-31 | 2010-05-18 | Advanced Cardiovascular Systems, Inc. | Composite guidewire with drawn and filled tube construction |
US7645242B1 (en) * | 1998-12-31 | 2010-01-12 | Advanced Cardiovascular Systems, Inc. | Composite guidewire with drawn and filled tube construction |
US6142975A (en) * | 1998-12-31 | 2000-11-07 | Advanced Cardiovascular Systems, Inc. | Guidewire having braided wire over drawn tube construction |
US6942654B1 (en) * | 2000-01-19 | 2005-09-13 | Scimed Life Systems, Inc. | Intravascular catheter with axial member |
DK1148839T3 (en) | 1999-02-01 | 2008-12-15 | Univ Texas | Woven two-branched and three-branched stents and methods of making them |
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US6187045B1 (en) * | 1999-02-10 | 2001-02-13 | Thomas K. Fehring | Enhanced biocompatible implants and alloys |
US6620192B1 (en) * | 1999-03-16 | 2003-09-16 | Advanced Cardiovascular Systems, Inc. | Multilayer stent |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
WO2001039695A2 (en) * | 1999-12-01 | 2001-06-07 | Advanced Cardiovascular Systems, Inc. | Nitinol alloy composition for vascular stents |
US6508832B1 (en) * | 1999-12-09 | 2003-01-21 | Advanced Cardiovascular Systems, Inc. | Implantable nickel-free stainless steel stents and method of making the same |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US7749245B2 (en) | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US6290722B1 (en) | 2000-03-13 | 2001-09-18 | Endovascular Technologies, Inc. | Tacky attachment method of covered materials on stents |
US7250058B1 (en) | 2000-03-24 | 2007-07-31 | Abbott Cardiovascular Systems Inc. | Radiopaque intraluminal stent |
DE60134223D1 (en) * | 2000-05-09 | 2008-07-10 | Paieon Inc | SYSTEM AND METHOD FOR THREE DIMENTIONAL RECONSTRUCTION OF AN ARTERY |
JP2003533335A (en) | 2000-05-22 | 2003-11-11 | オーバス メディカル テクノロジーズ インク. | Self-expanding stent |
US6800089B1 (en) | 2000-05-31 | 2004-10-05 | Advanced Cardiovascular Systems, Inc. | Mechanical attachment method of cover materials on stents |
WO2002005888A1 (en) | 2000-06-30 | 2002-01-24 | Viacor Incorporated | Intravascular filter with debris entrapment mechanism |
US6773454B2 (en) | 2000-08-02 | 2004-08-10 | Michael H. Wholey | Tapered endovascular stent graft and method of treating abdominal aortic aneurysms and distal iliac aneurysms |
US6799637B2 (en) | 2000-10-20 | 2004-10-05 | Schlumberger Technology Corporation | Expandable tubing and method |
AU2001285078A1 (en) | 2000-08-18 | 2002-03-04 | Atritech, Inc. | Expandable implant devices for filtering blood flow from atrial appendages |
AU2002230941A1 (en) * | 2000-10-31 | 2002-05-15 | Prodesco, Inc. | Supported lattice for cell cultivation |
US7976648B1 (en) | 2000-11-02 | 2011-07-12 | Abbott Cardiovascular Systems Inc. | Heat treatment for cold worked nitinol to impart a shape setting capability without eventually developing stress-induced martensite |
US6602272B2 (en) * | 2000-11-02 | 2003-08-05 | Advanced Cardiovascular Systems, Inc. | Devices configured from heat shaped, strain hardened nickel-titanium |
US6855161B2 (en) * | 2000-12-27 | 2005-02-15 | Advanced Cardiovascular Systems, Inc. | Radiopaque nitinol alloys for medical devices |
US20060086440A1 (en) * | 2000-12-27 | 2006-04-27 | Boylan John F | Nitinol alloy design for improved mechanical stability and broader superelastic operating window |
US7128757B2 (en) * | 2000-12-27 | 2006-10-31 | Advanced Cardiovascular, Inc. | Radiopaque and MRI compatible nitinol alloys for medical devices |
US6641607B1 (en) | 2000-12-29 | 2003-11-04 | Advanced Cardiovascular Systems, Inc. | Double tube stent |
NO335594B1 (en) | 2001-01-16 | 2015-01-12 | Halliburton Energy Serv Inc | Expandable devices and methods thereof |
US6551341B2 (en) | 2001-06-14 | 2003-04-22 | Advanced Cardiovascular Systems, Inc. | Devices configured from strain hardened Ni Ti tubing |
US7727221B2 (en) | 2001-06-27 | 2010-06-01 | Cardiac Pacemakers Inc. | Method and device for electrochemical formation of therapeutic species in vivo |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
US20030100945A1 (en) | 2001-11-23 | 2003-05-29 | Mindguard Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US7097659B2 (en) | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US7175655B1 (en) * | 2001-09-17 | 2007-02-13 | Endovascular Technologies, Inc. | Avoiding stress-induced martensitic transformation in nickel titanium alloys used in medical devices |
US20030181972A1 (en) * | 2002-03-22 | 2003-09-25 | Scimed Life Systems, Inc. | MRI and x-ray compatible stent material |
US8721713B2 (en) | 2002-04-23 | 2014-05-13 | Medtronic, Inc. | System for implanting a replacement valve |
US7105021B2 (en) * | 2002-04-25 | 2006-09-12 | Scimed Life Systems, Inc. | Implantable textile prostheses having PTFE cold drawn yarns |
US7357854B1 (en) | 2002-08-19 | 2008-04-15 | Advanced Cardiovascular Systems, Inc. | Process for electropolishing a device made from cobalt-chromium |
US9561123B2 (en) | 2002-08-30 | 2017-02-07 | C.R. Bard, Inc. | Highly flexible stent and method of manufacture |
US6878162B2 (en) | 2002-08-30 | 2005-04-12 | Edwards Lifesciences Ag | Helical stent having improved flexibility and expandability |
AU2003900617A0 (en) * | 2003-02-12 | 2003-02-27 | Australian Surgical Design And Manufacture Pty Limited | Surface preparation of an implant |
US20050155679A1 (en) * | 2003-04-09 | 2005-07-21 | Coastcast Corporation | CoCr alloys and methods for making same |
US7857916B2 (en) * | 2003-04-11 | 2010-12-28 | Nhk Spring Co., Ltd | Co-Cr-Mo alloy fine wire, manufacturing method therefor, and planar body, tubular body, stranded wire and cable formed of wire |
US7731747B2 (en) * | 2003-04-14 | 2010-06-08 | Tryton Medical, Inc. | Vascular bifurcation prosthesis with multiple thin fronds |
US7758630B2 (en) * | 2003-04-14 | 2010-07-20 | Tryton Medical, Inc. | Helical ostium support for treating vascular bifurcations |
US8109987B2 (en) * | 2003-04-14 | 2012-02-07 | Tryton Medical, Inc. | Method of treating a lumenal bifurcation |
US7717953B2 (en) * | 2004-10-13 | 2010-05-18 | Tryton Medical, Inc. | Delivery system for placement of prosthesis at luminal OS |
US8083791B2 (en) * | 2003-04-14 | 2011-12-27 | Tryton Medical, Inc. | Method of treating a lumenal bifurcation |
US7972372B2 (en) * | 2003-04-14 | 2011-07-05 | Tryton Medical, Inc. | Kit for treating vascular bifurcations |
US20100196345A1 (en) * | 2003-04-27 | 2010-08-05 | Protalix | Production of high mannose proteins in plant culture |
US7951557B2 (en) * | 2003-04-27 | 2011-05-31 | Protalix Ltd. | Human lysosomal proteins from plant cell culture |
US7942892B2 (en) * | 2003-05-01 | 2011-05-17 | Abbott Cardiovascular Systems Inc. | Radiopaque nitinol embolic protection frame |
US7520947B2 (en) * | 2003-05-23 | 2009-04-21 | Ati Properties, Inc. | Cobalt alloys, methods of making cobalt alloys, and implants and articles of manufacture made therefrom |
US9039755B2 (en) | 2003-06-27 | 2015-05-26 | Medinol Ltd. | Helical hybrid stent |
US9155639B2 (en) * | 2009-04-22 | 2015-10-13 | Medinol Ltd. | Helical hybrid stent |
US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
US8435285B2 (en) * | 2003-11-25 | 2013-05-07 | Boston Scientific Scimed, Inc. | Composite stent with inner and outer stent elements and method of using the same |
US20050113904A1 (en) * | 2003-11-25 | 2005-05-26 | Shank Peter J. | Composite stent with inner and outer stent elements and method of using the same |
US7186265B2 (en) * | 2003-12-10 | 2007-03-06 | Medtronic, Inc. | Prosthetic cardiac valves and systems and methods for implanting thereof |
US7955313B2 (en) * | 2003-12-17 | 2011-06-07 | Boston Scientific Scimed, Inc. | Composite catheter braid |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US20050137686A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical, A Delaware Corporation | Externally expandable heart valve anchor and method |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US7381219B2 (en) * | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US20050137696A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical | Apparatus and methods for protecting against embolization during endovascular heart valve replacement |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
CA2551111C (en) | 2003-12-23 | 2012-05-01 | Sadra Medical, Inc. | Repositionable heart valve |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US20050137691A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical | Two piece heart valve and anchor |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
US8052749B2 (en) | 2003-12-23 | 2011-11-08 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
US7988724B2 (en) | 2003-12-23 | 2011-08-02 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
CN101052359A (en) | 2004-04-23 | 2007-10-10 | 3F医疗有限公司 | Implantable prosthetic valve |
US20050273156A1 (en) * | 2004-06-07 | 2005-12-08 | Rober Burgermeister | Biocompatible alloy for implantable medical devices |
US20050276718A1 (en) * | 2004-06-09 | 2005-12-15 | Robert Burgermeister | Cobalt-nickel-chromium biocompatible alloy for implantable medical devices |
US7794493B2 (en) * | 2004-06-30 | 2010-09-14 | Cordis Corporation | Magnetic resonance imaging compatibility alloy for implantable medical devices |
DE102004041354A1 (en) | 2004-08-25 | 2006-03-30 | Buck, Alfred | Implant for surgical use in humans or vertebrates |
EP1789107B1 (en) | 2004-08-30 | 2009-05-27 | Interstitial Therapeutics | Medical stent provided with inhibitors of atp synthesis |
US20060060266A1 (en) * | 2004-09-01 | 2006-03-23 | Pst, Llc | Stent and method for manufacturing the stent |
US7763067B2 (en) | 2004-09-01 | 2010-07-27 | C. R. Bard, Inc. | Stent and method for manufacturing the stent |
US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
US20060100692A1 (en) * | 2004-11-09 | 2006-05-11 | Robert Burgermeister | Cobalt-chromium-molybdenum fatigue resistant alloy for intravascular medical devices |
US20060111649A1 (en) * | 2004-11-19 | 2006-05-25 | Scimed Life Systems, Inc. | Catheter having improved torque response and curve retention |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US20090038752A1 (en) * | 2005-02-09 | 2009-02-12 | Adel Weng | Reinforced balloon for a catheter |
ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
AU2006221046B2 (en) | 2005-03-03 | 2012-02-02 | Icon Medical Corp. | Improved metal alloys for medical device |
US9107899B2 (en) | 2005-03-03 | 2015-08-18 | Icon Medical Corporation | Metal alloys for medical devices |
US7452501B2 (en) * | 2005-03-03 | 2008-11-18 | Icon Medical Corp. | Metal alloy for a stent |
US7540995B2 (en) * | 2005-03-03 | 2009-06-02 | Icon Medical Corp. | Process for forming an improved metal alloy stent |
JP4710006B2 (en) * | 2005-03-28 | 2011-06-29 | 国立大学法人岩手大学 | Biocompatibility evaluation method for metal for biomedical use |
US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
WO2007035805A2 (en) * | 2005-09-20 | 2007-03-29 | Purdue Research Foundation | Biocompatable nanophase materials |
EP1945142B1 (en) | 2005-09-26 | 2013-12-25 | Medtronic, Inc. | Prosthetic cardiac and venous valves |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US9078781B2 (en) | 2006-01-11 | 2015-07-14 | Medtronic, Inc. | Sterile cover for compressible stents used in percutaneous device delivery systems |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US9456911B2 (en) | 2006-02-14 | 2016-10-04 | Angiomed Gmbh & Co. Medizintechnik | Highly flexible stent and method of manufacture |
EP2004095B1 (en) | 2006-03-28 | 2019-06-12 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US7318837B2 (en) * | 2006-03-30 | 2008-01-15 | Medtronic Vascular, Inc. | Customized alloys for stents |
US7625403B2 (en) | 2006-04-04 | 2009-12-01 | Medtronic Vascular, Inc. | Valved conduit designed for subsequent catheter delivered valve therapy |
US7524331B2 (en) * | 2006-04-06 | 2009-04-28 | Medtronic Vascular, Inc. | Catheter delivered valve having a barrier to provide an enhanced seal |
US7740655B2 (en) * | 2006-04-06 | 2010-06-22 | Medtronic Vascular, Inc. | Reinforced surgical conduit for implantation of a stented valve therein |
US7591848B2 (en) | 2006-04-06 | 2009-09-22 | Medtronic Vascular, Inc. | Riveted stent valve for percutaneous use |
US20070239269A1 (en) * | 2006-04-07 | 2007-10-11 | Medtronic Vascular, Inc. | Stented Valve Having Dull Struts |
US20070239271A1 (en) * | 2006-04-10 | 2007-10-11 | Than Nguyen | Systems and methods for loading a prosthesis onto a minimally invasive delivery system |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US20070244544A1 (en) * | 2006-04-14 | 2007-10-18 | Medtronic Vascular, Inc. | Seal for Enhanced Stented Valve Fixation |
US20070244545A1 (en) * | 2006-04-14 | 2007-10-18 | Medtronic Vascular, Inc. | Prosthetic Conduit With Radiopaque Symmetry Indicators |
US20070244546A1 (en) * | 2006-04-18 | 2007-10-18 | Medtronic Vascular, Inc. | Stent Foundation for Placement of a Stented Valve |
US10219884B2 (en) | 2006-07-10 | 2019-03-05 | First Quality Hygienic, Inc. | Resilient device |
US10004584B2 (en) | 2006-07-10 | 2018-06-26 | First Quality Hygienic, Inc. | Resilient intravaginal device |
US7717892B2 (en) * | 2006-07-10 | 2010-05-18 | Mcneil-Ppc, Inc. | Method of treating urinary incontinence |
JP5490533B2 (en) * | 2006-07-10 | 2014-05-14 | マクニール−ピーピーシー・インコーポレイテッド | Elastic device |
US8613698B2 (en) | 2006-07-10 | 2013-12-24 | Mcneil-Ppc, Inc. | Resilient device |
WO2008008291A2 (en) * | 2006-07-13 | 2008-01-17 | Icon Medical Corp. | Stent |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
WO2008034013A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices and methods of making the same |
WO2008034031A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making the same |
CA2663271A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making the same |
WO2008034048A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprosthesis with biostable inorganic layers |
WO2008036548A2 (en) | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Endoprostheses |
US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US8052750B2 (en) | 2006-09-19 | 2011-11-08 | Medtronic Ventor Technologies Ltd | Valve prosthesis fixation techniques using sandwiching |
DK2083901T3 (en) | 2006-10-16 | 2018-02-26 | Medtronic Ventor Tech Ltd | TRANSAPICAL DELIVERY SYSTEM WITH VENTRICULO-ARTERIAL OVERFLOW BYPASS |
CA2934168C (en) | 2006-10-22 | 2019-04-02 | Idev Technologies, Inc. | Devices and methods for stent advancement |
KR20130095317A (en) | 2006-10-22 | 2013-08-27 | 이데브 테크놀로지스, 아이엔씨. | Devices and methods for stent advancement |
WO2008083190A2 (en) | 2006-12-28 | 2008-07-10 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making same |
US8333799B2 (en) | 2007-02-12 | 2012-12-18 | C. R. Bard, Inc. | Highly flexible stent and method of manufacture |
EP2120785B1 (en) * | 2007-02-12 | 2021-12-01 | C.R. Bard, Inc. | Highly flexible stent and method of manufacture |
EP2129333B1 (en) | 2007-02-16 | 2019-04-03 | Medtronic, Inc | Replacement prosthetic heart valves |
US8177834B2 (en) * | 2007-03-12 | 2012-05-15 | Cook Medical Technologies Llc | Woven fabric with shape memory element strands |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
SG187447A1 (en) * | 2007-05-07 | 2013-02-28 | Protalix Ltd | Large scale disposable bioreactor |
US8398702B2 (en) * | 2007-06-29 | 2013-03-19 | Boston Scientific Scimed, Inc. | Molybdenum endoprostheses |
US7604662B2 (en) * | 2007-07-13 | 2009-10-20 | Boston Scientific Scimed, Inc. | Endoprostheses containing boride intermetallic phases |
US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US8118857B2 (en) * | 2007-11-29 | 2012-02-21 | Boston Scientific Corporation | Medical articles that stimulate endothelial cell migration |
US8834552B2 (en) * | 2007-12-27 | 2014-09-16 | Cook Medical Technologies Llc | Stent graft having floating yarns |
US8157853B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US8628566B2 (en) | 2008-01-24 | 2014-01-14 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9149358B2 (en) | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
EP2254512B1 (en) * | 2008-01-24 | 2016-01-06 | Medtronic, Inc. | Markers for prosthetic heart valves |
EP3744291B1 (en) | 2008-01-24 | 2022-11-23 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
ES2903231T3 (en) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
EP3005984A1 (en) | 2008-02-28 | 2016-04-13 | Medtronic Inc. | Prosthetic heart valve systems |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US8430927B2 (en) | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
US20090287301A1 (en) * | 2008-05-16 | 2009-11-19 | Boston Scientific, Scimed Inc. | Coating for medical implants |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
EP4018967A1 (en) | 2008-09-15 | 2022-06-29 | Medtronic Ventor Technologies Ltd | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
WO2010042950A2 (en) | 2008-10-10 | 2010-04-15 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
US8834563B2 (en) | 2008-12-23 | 2014-09-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US20100217370A1 (en) * | 2009-02-20 | 2010-08-26 | Boston Scientific Scimed, Inc. | Bioerodible Endoprosthesis |
EP2403546A2 (en) | 2009-03-02 | 2012-01-11 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
AU2010228091B2 (en) * | 2009-03-26 | 2016-06-16 | Bl Technologies, Inc. | Non-braided reinforced hollow fibre membrane |
EP2246011B1 (en) | 2009-04-27 | 2014-09-03 | Sorin Group Italia S.r.l. | Prosthetic vascular conduit |
US9572693B2 (en) * | 2009-05-14 | 2017-02-21 | Orbusneich Medical, Inc. | Self-expanding stent with polygon transition zone |
US8382818B2 (en) * | 2009-07-02 | 2013-02-26 | Tryton Medical, Inc. | Ostium support for treating vascular bifurcations |
US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US20110146361A1 (en) | 2009-12-22 | 2011-06-23 | Edwards Lifesciences Corporation | Method of Peening Metal Heart Valve Stents |
US20110152604A1 (en) * | 2009-12-23 | 2011-06-23 | Hull Jr Raymond J | Intravaginal incontinence device |
US8888838B2 (en) * | 2009-12-31 | 2014-11-18 | W. L. Gore & Associates, Inc. | Endoprosthesis containing multi-phase ferrous steel |
US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
US8398916B2 (en) * | 2010-03-04 | 2013-03-19 | Icon Medical Corp. | Method for forming a tubular medical device |
WO2011119573A1 (en) | 2010-03-23 | 2011-09-29 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US8658006B2 (en) | 2010-04-12 | 2014-02-25 | Abbott Cardiovascular Systems Inc. | System and method for electropolising devices |
DE102010018541A1 (en) * | 2010-04-28 | 2011-11-03 | Acandis Gmbh & Co. Kg | Method of manufacturing a medical device |
IT1400327B1 (en) | 2010-05-21 | 2013-05-24 | Sorin Biomedica Cardio Srl | SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT. |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
US9023095B2 (en) | 2010-05-27 | 2015-05-05 | Idev Technologies, Inc. | Stent delivery system with pusher assembly |
EP4052682A1 (en) | 2010-09-01 | 2022-09-07 | Medtronic Vascular Galway | Prosthetic valve support structure |
AU2011300644B2 (en) | 2010-09-10 | 2015-08-20 | Symetis Sa | Valve replacement devices and a system comprising the valve replacement device and a delivery device therefor |
US9566147B2 (en) | 2010-11-17 | 2017-02-14 | Abbott Cardiovascular Systems, Inc. | Radiopaque intraluminal stents comprising cobalt-based alloys containing one or more platinum group metals, refractory metals, or combinations thereof |
US11298251B2 (en) | 2010-11-17 | 2022-04-12 | Abbott Cardiovascular Systems, Inc. | Radiopaque intraluminal stents comprising cobalt-based alloys with primarily single-phase supersaturated tungsten content |
EP2642946B1 (en) | 2010-11-24 | 2023-08-16 | Poseidon Medical Inc. | Support for treating vascular bifurcations |
EP2486894B1 (en) | 2011-02-14 | 2021-06-09 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
EP2486893B1 (en) | 2011-02-14 | 2017-07-05 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
EP2688516B1 (en) | 2011-03-21 | 2022-08-17 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus |
EP2520251A1 (en) | 2011-05-05 | 2012-11-07 | Symetis SA | Method and Apparatus for Compressing Stent-Valves |
US9724494B2 (en) | 2011-06-29 | 2017-08-08 | Abbott Cardiovascular Systems, Inc. | Guide wire device including a solderable linear elastic nickel-titanium distal end section and methods of preparation therefor |
EP2731550B1 (en) | 2011-07-12 | 2016-02-24 | Boston Scientific Scimed, Inc. | Coupling system for a replacement valve |
US9131926B2 (en) | 2011-11-10 | 2015-09-15 | Boston Scientific Scimed, Inc. | Direct connect flush system |
US8940014B2 (en) | 2011-11-15 | 2015-01-27 | Boston Scientific Scimed, Inc. | Bond between components of a medical device |
US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US9510945B2 (en) | 2011-12-20 | 2016-12-06 | Boston Scientific Scimed Inc. | Medical device handle |
US9277993B2 (en) | 2011-12-20 | 2016-03-08 | Boston Scientific Scimed, Inc. | Medical device delivery systems |
EP2842517A1 (en) | 2011-12-29 | 2015-03-04 | Sorin Group Italia S.r.l. | A kit for implanting prosthetic vascular conduits |
WO2013112547A1 (en) | 2012-01-25 | 2013-08-01 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
WO2013119332A2 (en) | 2012-02-09 | 2013-08-15 | Stout Medical Group, L.P. | Embolic device and methods of use |
EP2841024B1 (en) | 2012-04-26 | 2017-05-03 | Tryton Medical, Inc. | Support for treating vascular bifurcations |
US9078753B2 (en) | 2012-05-03 | 2015-07-14 | Kennametal Inc. | Surgical orthopedic implants made from wear-resistant cobalt—chromium—molybdenum alloys |
US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
DE102013003434A1 (en) * | 2013-02-27 | 2014-08-28 | Gernot Hausch | Milling blank, useful for manufacturing dental prosthesis parts by CAD/computer-aided manufacturing method, comprises alloy containing specified amount of chromium, molybdenum, iron, manganese, silicon, nickel, carbon, nitrogen and cobalt |
WO2014179763A1 (en) | 2013-05-03 | 2014-11-06 | Medtronic Inc. | Valve delivery tool |
US8870948B1 (en) | 2013-07-17 | 2014-10-28 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
US20150045695A1 (en) * | 2013-08-06 | 2015-02-12 | Abbott Cardiovascular Systems, Inc. | Guide wire with core made from low-modulus cobalt-chromium alloy |
EP3038567B1 (en) | 2013-08-30 | 2022-09-07 | JenaValve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
CN103445894B (en) * | 2013-09-11 | 2016-05-25 | 辽宁生物医学材料研发中心有限公司 | Medical stainless steel intravascular stent |
US9060777B1 (en) | 2014-05-28 | 2015-06-23 | Tw Medical Technologies, Llc | Vaso-occlusive devices and methods of use |
WO2015184075A1 (en) | 2014-05-28 | 2015-12-03 | Stryker European Holdings I, Llc | Vaso-occlusive devices and methods of use |
CN106535826A (en) | 2014-06-24 | 2017-03-22 | 怡康医疗股份有限公司 | Improved metal alloys for medical devices |
US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
EP3229736B1 (en) | 2014-12-09 | 2024-01-10 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and method of manufacture |
WO2016115375A1 (en) | 2015-01-16 | 2016-07-21 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
US10201417B2 (en) | 2015-02-03 | 2019-02-12 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
EP3632378B1 (en) | 2015-05-01 | 2024-05-29 | JenaValve Technology, Inc. | Device with reduced pacemaker rate in heart valve replacement |
WO2016182949A1 (en) | 2015-05-08 | 2016-11-17 | Stryker European Holdings I, Llc | Vaso-occlusive devices |
EP3294221B1 (en) | 2015-05-14 | 2024-03-06 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
EP3294220B1 (en) | 2015-05-14 | 2023-12-06 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
WO2018136959A1 (en) | 2017-01-23 | 2018-07-26 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10427380B2 (en) | 2015-05-19 | 2019-10-01 | Apple Inc. | Methods of manufacturing corrosion resistant bimetal parts and bimetal parts formed therefrom |
WO2017004377A1 (en) | 2015-07-02 | 2017-01-05 | Boston Scientific Scimed, Inc. | Adjustable nosecone |
US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
US10779940B2 (en) | 2015-09-03 | 2020-09-22 | Boston Scientific Scimed, Inc. | Medical device handle |
US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
US11766506B2 (en) | 2016-03-04 | 2023-09-26 | Mirus Llc | Stent device for spinal fusion |
US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US10245136B2 (en) | 2016-05-13 | 2019-04-02 | Boston Scientific Scimed Inc. | Containment vessel with implant sheathing guide |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
EP3471665B1 (en) | 2016-06-17 | 2023-10-11 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices |
AU2018203053B2 (en) | 2017-01-23 | 2020-03-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
WO2018208662A1 (en) * | 2017-05-08 | 2018-11-15 | Baylor College Of Medicine | Bifurcated flow diverter systems |
US11969368B2 (en) * | 2017-05-12 | 2024-04-30 | Biotyx Medical (Shenzhen) Co., Ltd. | Lumen stent and preform thereof, and methods for preparing the lumen stent and preform thereof |
WO2018226915A1 (en) | 2017-06-08 | 2018-12-13 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
EP3661458A1 (en) | 2017-08-01 | 2020-06-10 | Boston Scientific Scimed, Inc. | Medical implant locking mechanism |
WO2019035966A1 (en) | 2017-08-16 | 2019-02-21 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
JP7047106B2 (en) | 2018-01-19 | 2022-04-04 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Medical device delivery system with feedback loop |
US11191641B2 (en) | 2018-01-19 | 2021-12-07 | Boston Scientific Scimed, Inc. | Inductance mode deployment sensors for transcatheter valve system |
WO2019157156A1 (en) | 2018-02-07 | 2019-08-15 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
US11439732B2 (en) | 2018-02-26 | 2022-09-13 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
EP3761864B1 (en) | 2018-03-05 | 2024-05-01 | University of Connecticut | Method of manufacturing a microneedle assembly |
CA3095163C (en) * | 2018-04-09 | 2023-10-03 | Boston Scientific Scimed, Inc. | Stent |
CN108514677A (en) | 2018-04-28 | 2018-09-11 | 业聚医疗器械(深圳)有限公司 | A kind of microtubular |
US11229517B2 (en) | 2018-05-15 | 2022-01-25 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
WO2019241477A1 (en) | 2018-06-13 | 2019-12-19 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
EP3943143A3 (en) | 2018-09-10 | 2022-03-02 | Orbusneich Medical Pte. Ltd | Variable flexibility catheter support frame |
JP7353300B2 (en) | 2018-11-22 | 2023-09-29 | 田中貴金属工業株式会社 | Medical Pt-Co alloy |
US11241312B2 (en) | 2018-12-10 | 2022-02-08 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
US11745001B2 (en) | 2020-03-10 | 2023-09-05 | University Of Connecticut | Therapeutic bandage |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3861909A (en) * | 1970-05-11 | 1975-01-21 | Carpenter Technology Corp | High strength steel alloy |
US4281419A (en) * | 1979-12-10 | 1981-08-04 | Richards Manufacturing Company, Inc. | Middle ear ossicular replacement prosthesis having a movable joint |
SE445884B (en) * | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
US4668290A (en) * | 1985-08-13 | 1987-05-26 | Pfizer Hospital Products Group Inc. | Dispersion strengthened cobalt-chromium-molybdenum alloy produced by gas atomization |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4681110A (en) * | 1985-12-02 | 1987-07-21 | Wiktor Dominik M | Catheter arrangement having a blood vessel liner, and method of using it |
US4731084A (en) * | 1986-03-14 | 1988-03-15 | Richards Medical Company | Prosthetic ligament |
SE453258B (en) * | 1986-04-21 | 1988-01-25 | Medinvent Sa | ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING |
US5024232A (en) * | 1986-10-07 | 1991-06-18 | The Research Foundation Of State University Of Ny | Novel radiopaque heavy metal polymer complexes, compositions of matter and articles prepared therefrom |
IT1202558B (en) * | 1987-02-17 | 1989-02-09 | Alberto Arpesani | INTERNAL PROSTHESIS FOR THE REPLACEMENT OF A PART OF THE HUMAN BODY PARTICULARLY IN THE VASCULAR OPERATIONS |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
CA2073965C (en) * | 1990-01-15 | 1999-02-16 | David Stuart Brookstein | Apparatus for making a braid structure |
US5064435A (en) * | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5383925A (en) * | 1992-09-14 | 1995-01-24 | Meadox Medicals, Inc. | Three-dimensional braided soft tissue prosthesis |
DE69219593T2 (en) * | 1991-03-25 | 1998-01-02 | Meadox Medicals Inc | Vascular prosthesis |
US5562725A (en) * | 1992-09-14 | 1996-10-08 | Meadox Medicals Inc. | Radially self-expanding implantable intraluminal device |
US5382259A (en) * | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
ATE207728T1 (en) * | 1993-01-19 | 2001-11-15 | Schneider Usa Inc | IMPLANTABLE WIRE IN COMPOSITE CONSTRUCTION |
US5308412A (en) * | 1993-03-15 | 1994-05-03 | Zimmer, Inc. | Method of surface hardening cobalt-chromium based alloys for orthopedic implant devices |
WO1994024961A1 (en) * | 1993-04-23 | 1994-11-10 | Schneider (Usa) Inc. | Covered stent and stent delivery device |
US5389106A (en) * | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5636641A (en) * | 1994-07-25 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | High strength member for intracorporeal use |
-
1996
- 1996-04-30 US US08/640,253 patent/US5891191A/en not_active Expired - Lifetime
-
1997
- 1997-03-27 PT PT97302192T patent/PT804934E/en unknown
- 1997-03-27 DK DK97302192T patent/DK0804934T3/en active
- 1997-03-27 ES ES97302192T patent/ES2202546T3/en not_active Expired - Lifetime
- 1997-03-27 DE DE69723905T patent/DE69723905T2/en not_active Expired - Lifetime
- 1997-03-27 EP EP97302192A patent/EP0804934B1/en not_active Expired - Lifetime
- 1997-03-27 AT AT97302192T patent/ATE246526T1/en not_active IP Right Cessation
- 1997-04-02 CA CA002201542A patent/CA2201542C/en not_active Expired - Fee Related
- 1997-04-29 AU AU19927/97A patent/AU726102B2/en not_active Ceased
- 1997-04-29 MX MX9703231A patent/MX9703231A/en not_active Application Discontinuation
- 1997-04-30 JP JP12630697A patent/JPH1043314A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA97003231A (en) | Implantable and grafted protestism of allocation protosisimplantable cobalt-cromo-molibd | |
EP0804934B1 (en) | Cobalt-chromium-molybdenum alloy stent and stent-graft | |
AU729170B2 (en) | Three-dimensional braided covered stent | |
US6592617B2 (en) | Three-dimensional braided covered stent | |
US5758562A (en) | Process for manufacturing braided composite prosthesis | |
US6689162B1 (en) | Braided composite prosthesis | |
KR0147482B1 (en) | Clad composite stent | |
CA2238781C (en) | Bioabsorbable self-expanding stent | |
DE60117169T2 (en) | STENT WITH CONTROLLED EXPANDABILITY | |
DE69832218T2 (en) | Stent-graft with a braided sleeve made of polymer material and process for its preparation | |
US20070219642A1 (en) | Hybrid stent having a fiber or wire backbone |